Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Ting Zhao

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 27, 2011
High prevalence of brown adipose tissue in adult humansPaul Lee, Jing Ting Zhao, Michael M Swarbrick, et al.
Molecular and Cellular Endocrinology|October 15, 2011
Dysregulation of microRNAs in adrenocortical tumorsPuneet Singh, Patsy S H Soon, Jean-Jacques Feige, et al.
Non-Coding RNA Research|August 31, 2018
Translational applications of microRNAs in cancer, and therapeutic implicationsGrace T Kwok, Jing Ting Zhao, Jocelyn Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2023
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged NanocellsVinod Ganju, Gavin Marx, Scott Pattison, et al.
ANZ Journal of Surgery|November 27, 2013
Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronismJulian C Y Ip, Tony C Y Pang, Cindy K Pon, et al.
ANZ Journal of Surgery|February 3, 2019
Treatment and management of adrenal cancer in a specialized Australian endocrine surgical unit: approaches, outcomes and lessons learntGrace T Y Kwok, Jing-Ting Zhao, Anthony R Glover, et al.
The Oncologist|March 29, 2019
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical CarcinomaGrace T Y Kwok, Jing Ting Zhao, Anthony R Glover, et al.
The Oncologist|February 7, 2015
Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersJulian C Y Ip, Tony C Y Pang, Anthony R Glover, et al.
Journal of Cardiovascular Electrophysiology|June 4, 2009
Not all hERG pore domain mutations have a severe phenotype: G584S has an inactivation gating defect with mild phenotype compared to G572S, which has a dominant negative trafficking defect and a severe phenotypeJing Ting Zhao, Adam P Hill, Anthony Varghese, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2019
RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid CarcinomaLauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|May 27, 2011
High prevalence of brown adipose tissue in adult humansPaul Lee, Jing Ting Zhao, Michael M Swarbrick, et al.
Molecular and Cellular Endocrinology|October 15, 2011
Dysregulation of microRNAs in adrenocortical tumorsPuneet Singh, Patsy S H Soon, Jean-Jacques Feige, et al.
Non-Coding RNA Research|August 31, 2018
Translational applications of microRNAs in cancer, and therapeutic implicationsGrace T Kwok, Jing Ting Zhao, Jocelyn Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2023
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged NanocellsVinod Ganju, Gavin Marx, Scott Pattison, et al.
ANZ Journal of Surgery|November 27, 2013
Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronismJulian C Y Ip, Tony C Y Pang, Cindy K Pon, et al.
ANZ Journal of Surgery|February 3, 2019
Treatment and management of adrenal cancer in a specialized Australian endocrine surgical unit: approaches, outcomes and lessons learntGrace T Y Kwok, Jing-Ting Zhao, Anthony R Glover, et al.
The Oncologist|March 29, 2019
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical CarcinomaGrace T Y Kwok, Jing Ting Zhao, Anthony R Glover, et al.
The Oncologist|February 7, 2015
Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersJulian C Y Ip, Tony C Y Pang, Anthony R Glover, et al.
Journal of Cardiovascular Electrophysiology|June 4, 2009
Not all hERG pore domain mutations have a severe phenotype: G584S has an inactivation gating defect with mild phenotype compared to G572S, which has a dominant negative trafficking defect and a severe phenotypeJing Ting Zhao, Adam P Hill, Anthony Varghese, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2019
RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid CarcinomaLauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, et al.
Pageof 3